Mattia Veronese Selected Research

Interferons

1/2021

Increased serum peripheral C-reactive protein is associated with reduced brain barriers permeability of TSPO radioligands in healthy volunteers and depressed patients: implications for inflammation and depression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mattia Veronese Research Topics

Disease

33	Schizophrenia (Dementia Praecox) 04/2024 - 01/2016
28	Psychotic Disorders (Schizoaffective Disorder) 05/2023 - 01/2016
10	Neuroinflammatory Diseases 01/2022 - 06/2014
7	Multiple Sclerosis 01/2021 - 01/2016
5	Inflammation (Inflammations) 01/2021 - 01/2019
4	Cognitive Dysfunction 02/2024 - 01/2018
3	Autism Spectrum Disorder 01/2022 - 10/2018
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 12/2017
2	Genetic Risk Score 04/2024 - 09/2023
2	Treatment-Resistant Schizophrenia 07/2022 - 03/2017
2	Paranoid Schizophrenia (Delusional Disorder) 07/2022 - 10/2020
2	Chronic Pain 01/2022 - 01/2022
2	Low Back Pain (Lumbago) 01/2022 - 01/2018
2	Obesity 08/2020 - 01/2019
2	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 12/2017
2	Alzheimer Disease (Alzheimer's Disease) 10/2019 - 03/2016
2	Fragile X Syndrome (Martin Bell Syndrome) 01/2019 - 01/2018
2	Hypoxia (Hypoxemia) 01/2019 - 11/2013
2	Mental Disorders (Mental Disorder) 11/2017 - 01/2017
1	Human Influenza (Influenza) 11/2023
1	Pain (Aches) 12/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Fibromyalgia (Fibrositis) 01/2022
1	Knee Osteoarthritis 01/2022
1	Necrosis 12/2021
1	Atrophy 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Fatigue 01/2021
1	Primary Progressive Aphasia 01/2021
1	Hallucinations (Hallucination) 10/2020
1	Dyslipidemias (Dyslipidemia) 08/2020
1	Cardiotoxicity 01/2019
1	Substance-Related Disorders (Drug Abuse) 01/2019

Drug/Important Bio-Agent (IBA)

24	Dopamine (Intropin)FDA LinkGeneric 04/2024 - 03/2017
18	Antipsychotic Agents (Antipsychotics)IBA 01/2023 - 03/2017
14	Proteins (Proteins, Gene)FDA Link 10/2021 - 06/2014
9	Dihydroxyphenylalanine (Dopa)IBA 05/2023 - 03/2017
8	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2017
7	Glutamic Acid (Glutamate)FDA Link 02/2024 - 10/2018
6	Amyloid (Amyloid Fibrils)IBA 11/2023 - 03/2016
4	Polytetrafluoroethylene (Teflon)FDA Link 01/2023 - 10/2019
4	LigandsIBA 12/2021 - 01/2018
4	CannabinoidsIBA 06/2021 - 10/2019
3	Ketamine FDA LinkGeneric 10/2023 - 01/2021
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 02/2016
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2022 - 12/2021
3	N- benzyl- N- ethyl- 2- (7,8- dihydro- 7- methyl- 8- oxo- 2- phenyl- 9H- purin- 9- yl)acetamideIBA 10/2021 - 01/2018
3	(methyl- (11)C)N- acetyl- N- (2- methoxybenzyl)- 2- phenoxy- 5- pyridinamineIBA 01/2021 - 01/2018
3	Clozapine (Clozaril)FDA LinkGeneric 01/2021 - 03/2017
2	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 11/2023 - 01/2021
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2023 - 11/2020
2	Protons (Proton)IBA 01/2023 - 10/2018
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2022 - 01/2021
2	CytokinesIBA 01/2022 - 12/2021
2	Alanine (L-Alanine)FDA Link 01/2019 - 12/2017
2	Aminobutyrates (Aminobutyric Acid)IBA 10/2018 - 01/2017
1	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2023
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 10/2023
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023
1	Dopamine AntagonistsIBA 01/2023
1	Opioid Analgesics (Opioids)IBA 12/2022
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 12/2022
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 12/2022
1	benzonitrileIBA 01/2022
1	Pain-FreeIBA 01/2022
1	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2022
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2022
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2022
1	Protein AggregatesIBA 01/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2021
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2021
1	C-Reactive ProteinIBA 01/2021
1	EndotoxinsIBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	InterferonsIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Monoamine Oxidase (MAO)IBA 01/2021
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Selegiline (E250)FDA LinkGeneric 01/2021
1	GABA Receptors (GABA Receptor)IBA 01/2021
1	RacloprideIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2021
1	Serotonin 5-HT1 Receptor AgonistsIBA 01/2021
1	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2021
1	EndocannabinoidsIBA 08/2020
1	florbetapirIBA 01/2020
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 10/2019
1	AnthracyclinesIBA 01/2019
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 01/2019
1	IonophoresIBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)IBA 01/2019

Therapy/Procedure

1	Analgesia 01/2022
1	Catheters 12/2021
1	Subcutaneous Injections 01/2021